Myrexis, Inc.
DelistedCIK 1459450fmd_1XPAKT893H99J7TZDQRYA30SYQManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2009 to Jun 30, 2013, 13 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 |
|---|---|---|---|---|
| Total revenues | 0 | 0 | – | – |
| Research and development | 28 | 22 | 14 | 0 |
| Operating income | (48) | (40) | (32) | (12) |
| Interest and investment income | – | – | – | 0 |
| Net income | (47) | (39) | (31) | (12) |